{"result_id": "086035", "URL": "https://www.cureus.com/articles/114641", "timestamp": "2023-04-25 14:53:32 CEST+0200", "meta": {"description": "Objectives: Several government-sponsored reporting systems have stated mild to moderate side effects of COVID-19 vaccines. However, patient-reported data on COVID-19 vaccine-associated adverse effects in adolescents are lacking. Our objective was to assess the short-term side effects of Pfizer-BioNTech BNT162b2 or Moderna mRNA-1273 vaccinations among teenagers in Saudi Arabia.\n\nMethods: A retrospective, cross-sectional study\u00a0was\u00a0conducted among\u00a0individuals\u00a0aged 12-18 years old\u00a0who received\u00a0one of the two mentioned\u00a0vaccines between July 2021\u00a0and\u00a0March 2022 in Riyadh, Saudi Arabia.\n\nResults: The most common short-term side effects reported for COVID-19 vaccines among teenagers in our study were fatigue, pain at the site of injection, fever, chills, headache, nausea, and vomiting. Female participants, individuals who had a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and those who received two doses of the vaccine are at higher risk to develop side effects after getting the vaccine. Importantly, asthmatic participants have a higher incidence of COVID-19 vaccine side effects when compared to those with no history of chronic diseases.\n\nConclusion: Our findings might enhance\u00a0public trust in the COVID-19 vaccine, which could speed up the immunization procedure.", "lang": "en", "keywords": "", "favicon": "https://assets.cureus.com/packs/media/images/favicon-6b3259c58f4356da2cc885357cfda20b.png", "canonical": "https://www.cureus.com/articles/114641", "encoding": "utf-8"}, "image": null, "domain": "www.cureus.com", "title": "Evaluation of Short-Term Symptoms Associated With COVID-19 Vaccines Used Among Adolescents in Saudi Arabia", "cleaned_text": "On May 25, 2018, the GDPR (General Data Protection Regulation) went into effect and changed how organizations deal with personal data of customers located in the EU. Though GDPR was built to protect Europeans, it will affect organizations around the world doing business in the EU. Because of this we are asking our users located in the EU to opt in to the data we collect in order to bring a better web experience. Opt-In", "opengraph": {"title": "Evaluation of Short-Term Symptoms Associated With COVID-19 Vaccines Used Among Adolescents in Saudi Arabia", "type": "article", "image": "https://assets.cureus.com/uploads/figure/file/453616/article_river_b27def9032c411eda4140b3537c16848-Figure-Post-vaccination-side-effect.png", "description": "Objectives: Several government-sponsored reporting systems have stated mild to moderate side effects of COVID-19 vaccines. However, patient-reported data on COVID-19 vaccine-associated adverse effects in adolescents are lacking. Our objective was to assess the short-term side effects of Pfizer-BioNTech BNT162b2 or Moderna mRNA-1273 vaccinations among teenagers in Saudi Arabia.\n\nMethods: A retrospective, cross-sectional study\u00a0was\u00a0conducted among\u00a0individuals\u00a0aged 12-18 years old\u00a0who received\u00a0one of the two mentioned\u00a0vaccines between July 2021\u00a0and\u00a0March 2022 in Riyadh, Saudi Arabia.\n\nResults: The most common short-term side effects reported for COVID-19 vaccines among teenagers in our study were fatigue, pain at the site of injection, fever, chills, headache, nausea, and vomiting. Female participants, individuals who had a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and those who received two doses of the vaccine are at higher risk to develop side effects after getting the vaccine. Importantly, asthmatic participants have a higher incidence of COVID-19 vaccine side effects when compared to those with no history of chronic diseases.\n\nConclusion: Our findings might enhance\u00a0public trust in the COVID-19 vaccine, which could speed up the immunization procedure."}, "tags": [], "tweets": [], "movies": [], "links": ["/users/gdpr_opt_in"], "authors": ["Fares  Alrowdhan Sr.", "Suliman  A. Alenazi", "Abdulaziz S. Altala", "Abdulnasser Alwably", "Mhd Noor Farawaty", "Rakan S. Shaheen", "Einas M. Yousef", "Hassan  Alfaraj", "Mhd Noor  Farawaty", "Rakan  S. Shaheen", "Hassan Alfaraj", "Fares K. Alrowdhan", "Suliman A. Alenazi", "Abdulaziz  S. Altala Sr.", "Abdulnasser  Alwably"], "publish_date": null}